Axa’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-173,495
| Closed | -$15.8M | – | 1067 |
|
|
2023
Q2 | $15.8M | Buy |
173,495
+2,386
| +1% | +$217K | 0.05% | 327 |
|
|
2023
Q1 | $11.3M | Buy |
171,109
+25,405
| +17% | +$1.68M | 0.04% | 391 |
|
|
2022
Q4 | $7.53M | Sell |
145,704
-784
| -0.5% | -$40.5K | 0.03% | 501 |
|
|
2022
Q3 | $10M | Buy |
146,488
+68,183
| +87% | +$4.66M | 0.04% | 434 |
|
|
2022
Q2 | $3.54M | Buy |
+78,305
| New | +$3.54M | 0.01% | 654 |
|
|
2021
Q3 | – | Sell |
-41,321
| Closed | -$2.61M | – | 1227 |
|
|
2021
Q2 | $2.61M | Sell |
41,321
-3,140
| -7% | -$198K | 0.01% | 842 |
|
|
2021
Q1 | $1.91M | Sell |
44,461
-166,647
| -79% | -$7.15M | 0.01% | 859 |
|
|
2020
Q4 | $12.1M | Buy |
211,108
+21,681
| +11% | +$1.24M | 0.04% | 460 |
|
|
2020
Q3 | $5.72M | Buy |
189,427
+18,793
| +11% | +$567K | 0.02% | 589 |
|
|
2020
Q2 | $5.57M | Buy |
170,634
+10,143
| +6% | +$331K | 0.02% | 584 |
|
|
2020
Q1 | $4.3M | Buy |
160,491
+66,200
| +70% | +$1.77M | 0.02% | 557 |
|
|
2019
Q4 | $2.89M | Buy |
+94,291
| New | +$2.89M | 0.01% | 744 |
|